Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? EQUITY

v3.22.2
STOCKHOLDERS’ EQUITY
 6 Months Ended
Jun. 30, 2022
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

7. STOCKHOLDERS’ EQUITY

 

COMMON STOCK

 

During the six months ended June 30, 2022, the Company issued an aggregate of 19,942 shares of common stock pursuant to exercises of warrants to purchase an aggregate of 19,942 shares of common stock for aggregate net proceeds of $82.

 

During the six months ended June 30, 2022, the Company issued an aggregate of 5,955 shares of common stock pursuant to exercises of warrants to purchase an aggregate of 5,955 shares of common stock for aggregate net proceeds of $10.

 

During the six months ended June 30, 2022, the Company issued an aggregate of 144,497 shares of common stock for services to employees and consultants with an aggregate issuance date fair value of $331.

 

See Note 4 – Business Combinations – Electric Blue Limited Acquisition and SemaConnect Acquisition for additional information of common stock issued as partial consideration for acquisitions.

 

STOCK-BASED COMPENSATION

 

The Company recognized stock-based compensation expense related to common stock, stock options and warrants for the three and six months ended June 30, 2022 of $1,027 and $2,989, respectively, which is included within compensation expense on the condensed consolidated statements of operations. The Company recognized stock-based compensation expense related to common stock and stock options for the three and six months ended June 30, 2021 of $3,670 and $4,084, respectively, As of June 30, 2022, there was $5,444 of unrecognized stock-based compensation expense that will be recognized over the weighted average remaining vesting period of 2.81 years.